20240010659. NEW THIADIAZOLOPYRIMIDONE DERIVATIVES simplified abstract (Hoffmann-La Roche Inc.)
Jump to navigation
Jump to search
Contents
NEW THIADIAZOLOPYRIMIDONE DERIVATIVES
Organization Name
Inventor(s)
Cosimo Dolente of Allschwil (CH)
Nadine Grether of Moehlin (CH)
Fionn Susannah O'hara of Basel (CH)
Michael Reutlinger of Freiburg (DE)
Claudio Zambaldo of Basel (CH)
NEW THIADIAZOLOPYRIMIDONE DERIVATIVES - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240010659 titled 'NEW THIADIAZOLOPYRIMIDONE DERIVATIVES
Simplified Explanation
The abstract of the patent application describes a compound of formula (i) that can be used as a medicament. The patent application provides a simplified explanation of the invention without overselling anything.
- The compound of formula (i) is defined in the description and claims of the patent application.
- The compound can be used as a medicament, indicating its potential use in medical treatments.
- The patent application does not provide a specific title.
Potential Applications
- The compound of formula (i) can be used in the development of new drugs or treatments.
- It may have applications in various medical fields, such as pharmaceuticals, biotechnology, or healthcare.
Problems Solved
- The compound may address specific medical conditions or diseases.
- It could potentially offer a solution to a previously unmet medical need.
- The patent application does not provide specific details about the problems solved.
Benefits
- The compound of formula (i) may provide therapeutic benefits to patients.
- It could offer improved treatment options or outcomes compared to existing medications.
- The patent application does not provide specific details about the benefits of the technology.
Original Abstract Submitted
wherein r-rand aare as defined in the description and in the claims. the compound of formula (i) can be used as a medicament.
